Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 1.19% | 171.71 | 1.3% | $501.07m | |
| BIIB | Biogen Inc. | 1.43% | 236.25 | 1.3% | $486.12m | |
| CELG | Celgene Corporation | 0.19% | 96.43 | 1.3% | $469.50m | |
| GILD | Gilead Sciences, Inc. | 0.00% | 66.52 | 0.9% | $452.15m | |
| ILMN | Illumina, Inc. | 2.21% | 313.25 | 3.5% | $316.64m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.24% | 319.98 | 2.6% | $293.71m | |
| A | Agilent Technologies, Inc. | -0.19% | 68.19 | 1.6% | $199.57m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.86% | 173.95 | 1.9% | $182.65m | |
| EXAS | Exact Sciences Corporation | -1.50% | 95.50 | 25.3% | $168.27m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.37% | 128.33 | 2.0% | $150.89m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.60% | 88.00 | 4.3% | $118.41m | |
| SRPT | Sarepta Therapeutics, Inc. | 0.78% | 122.14 | 14.7% | $116.38m | |
| INCY | Incyte Corporation | 0.93% | 79.41 | 2.5% | $107.73m | |
| IONS | Ionis Pharmaceuticals, Inc. | -0.88% | 68.63 | 8.2% | $98.48m | |
| ALNY | Alnylam Pharmaceuticals, Inc | 1.08% | 68.60 | 9.2% | $96.64m |
Company Profile
BioMarin Pharmaceutical, Inc. is a biotechnology company, which develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its products include Aldurazyme, Brineura, Kuvan, Naglazyme, Palynziq and Vimizim. The company was founded by Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.